This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...